Crossmark

Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study

Published Online: 2021-08-13

Published Print: 2021-09

Authors

Kanamori, Rie

Yamane, Shiho

Seto, Takeshi
Funding

Funding for this research was provided by:

Sanofi K.K.
License Information

Text and Data Mining valid from 2021-08-13

Version of Record valid from 2021-08-13
More Information

Article History

Received: 6 May 2021

Accepted: 16 July 2021

First Online: 13 August 2021

Document is current